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Chromatin immunoprecipitationGenomic imprinting at the Delta-like 1 (Dlk1)–Maternally expressed gene 3 (Meg3) locus is regulated by the
Meg3 differentially methylated region (DMR), but the mechanism by which this DMR acts is unknown. The
goal of this study was to analyze the Meg3 DMR during imprinting establishment and maintenance for the
presence of histone modiﬁcations and trans-acting DNA binding proteins using chromatin immunoprecipita-
tion. In embryonic stem (ES) cells, where Meg3 is biallelically expressed, the DMR showed variable DNA
methylation, with biallelic methylation at one region but paternal allele-speciﬁc methylation at another.
All histone modiﬁcations detected at the Meg3 DMR of ES cells were biallelic. In embryonic day 12.5
(e12.5) embryos, whereMeg3 is maternally expressed, the paternal Meg3 DMR was methylated, and activat-
ing histone modiﬁcations were speciﬁc to the maternal DMR. DNA-binding proteins that represent potential
regulatory factors were identiﬁed in both ES cells and embryos.
© 2012 Elsevier Inc. All rights reserved.1. Introduction
Genomic imprinting is the differential expression of the two al-
leles of a gene based on their parent of origin. For a gene to be
imprinted, each chromosome must be marked such that the tran-
scriptional machinery is able to distinguish the parental alleles. Ex-
amples of such imprinting marks are DNA (CpG) methylation and
covalent modiﬁcations to histone proteins. At imprinted genes, DNA
methylation is applied in a parent-of-origin speciﬁc manner at CpG
islands within differentially methylated regions (DMRs). DMRs have
proven to be critical for maintenance of imprinting, as deletion or mu-
tation of these regions often results in loss of imprinting [1–5]. Core
histone proteins have N-terminal tails to which acetyl, methyl,
SUMO, ubiquitin, and phosphate groups can be added to inﬂuence ex-
pression of associated genes.
The imprinted Dlk1–Meg3 locus is located on distal mouse chromo-
some 12 (human 14q32) and contains the paternally expressed
Delta-like 1 (Dlk1) gene and the maternally expressed Maternally
expressed gene 3 (Meg3) gene, along with several additional maternally-
expressed noncoding genes (Fig. 1A and data not shown) [6–8]. Dlk1
encodes a transmembrane protein belonging to the Notch signaling
family [9].Meg3, previously knownasGene trap locus 2 (Gtl2), was discov-
ered by gene trap insertion, and produces amultiply spliced, untranslated
RNA of unknown function [10,11]. Within the Dlk1–Meg3 region lie three
DMRs that are methylated solely on the paternal chromosome: the Dlk1Sciences, University of Illinois
60607, USA. Fax: +1 312 413
rights reserved.DMR located at the 3′ endof theDlk1 gene, the intergenic (IG)-DMR locat-
ed 13 kb upstream of Meg3, and the Meg3 DMR, which begins approxi-
mately 1.5 kb upstream of the Meg3 transcriptional initiation site and
ends within the ﬁrst intron of Meg3 (Fig. 1A) [6,7,12]. Deletion of the
IG-DMR has demonstrated that it is required for maternal, but not pater-
nal, imprinting at this locus [3]. Previous studies suggest that the Meg3
DMR is necessary for proper Dlk1–Meg3 imprinting on both parental
chromosomes, but the mechanism by which the Meg3 DMR controls
imprinting is not well understood [5,13,14].
Steshina et al. [5] generated Gtl2Δ5′Neo mice by replacing a 2.8 kb
region upstream ofMeg3 with the Neomycin (Neo) gene. One hundred
base pairs of the Meg3 DMR were deleted by this mutation, but the
remainder of the Meg3 DMR and the Meg3 promoter were left
undisturbed. Altered expression of Dlk1 and Meg3 was detected when
the transgenewas passed eithermaternally or paternally, and these ab-
normal expression levels were due to loss of imprinting (LOI) of the
normally silent allele on the chromosome carrying the mutation. LOI
upon paternal transmission of the Gtl2Δ5′Neo allele, and the associated
biallelic expression ofMeg3, appeared to result from the loss of paternal
Meg3 DMR methylation. No methylation change was seen after mater-
nal transmission of the Gtl2Δ5′Neo allele, where Dlk1 is biallelically
expressed, so the molecular mechanism of maternal LOI is unknown.
Similar LOI and methylation changes were observed in Gtl2lacZ mice,
which carry a lacZ/β-actin-Neo transgene insertion 2.3 kb upstream of
Meg3, in a position analogous to that of Neo in the Gtl2Δ5′Neo mice
[10,13]. These data suggest that theMeg3 upstream region plays a reg-
ulatory role in Dlk1–Meg3 imprinting on both chromosomes, with per-
turbation of this region resulting in LOI.
Carr et al. used chromatin immunoprecipitation (ChIP) experi-
ments on midgestation mouse embryos to search for imprinting
Fig. 1. Regions of the Meg3 DMR analyzed for epigenetic status. (A) Genomic organization of the Dlk1–Meg3 domain. Black boxes represent exons and gray boxes represent DMRs.
(B) Depiction of the Meg3 DMR. The gray box represents the Meg3 DMR, and the black box represents Meg3 exon 1. Regions of the Meg3 DMR analyzed by ChIP are indicated by
horizontal lines below the DMR. (C) Meg3 DMR methylation analysis in ES cells and e12.5 embryos. D, C, D×C ES cell, and D×Cg12 e12.5 embryo genomic DNA was digested
with HpaII, ampliﬁed with region 3 (R3) and region 9 (R9) primers, and cut with the appropriate restriction enzyme to determine DNA methylation allele speciﬁcity. The uncut
DNA is represented by “−”, while “+” denotes DNA cut with the appropriate restriction enzyme; %M indicates the amount of methylation on the maternal allele relative to the
total methylation. (D) Meg3 expression analysis in e12.5 embryos and ES cells, using D, C, D×C, and C×D e12.5 embryo cDNA and D×C ES cell cDNA for analysis. Uncut DNA is
represented by “−”, while “+” denotes SfcI cut DNA, %M indicates the amount of methylation on the maternal allele relative to the total level of methylation.
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the sites tested was located in the Meg3 DMR, and while this region
displayed high levels of maternal-speciﬁc acetylation of histones H3
and H4, little evidence was found for other allele-speciﬁc histone
modiﬁcations. The goal of the current study was a more detailed char-
acterization of the allele-speciﬁc epigenetic proﬁle of the Meg3 DMR,
incorporating chromosomal regions and epigenetic modiﬁcations not
previously examined. ChIP was ﬁrst conducted using chromatin from
embryonic stem (ES) cells to determine the epigenetic status of this
region at the time imprinted expression is being established. ChIP
was then performed using embryonic day 12.5 (e12.5) midgestation
embryos, a developmental time point when Dlk1 and Meg3 display
fully imprinted expression. The resulting data provide a more com-
plete picture of how imprinting is regulated at the Dlk1–Meg3 region.
2. Results
2.1. Methylation status of the Meg3 DMR and imprinting analysis of
Meg3 in ES cells and e12.5 embryos
To conduct an in-depth analysis of histone modiﬁcations and
DNA-binding proteins present at the Meg3 DMR, primers were
designed to amplify nine overlapping 300-base pair regions of theDMR (Fig. 1B, Supplementary Table 1). In e12.5 embryos, the Meg3
DMR is methylated on the paternal allele, and theMeg3 gene is mater-
nally expressed [6]. To our knowledge, neither the methylation proﬁle
of the Meg3 DMR, nor the expression status of the Meg3 gene, has
been determined in ES cells. To determine the allele-speciﬁc methyla-
tion status of the Meg3 DMR in ES cells and e12.5 embryos, the DMR
wasﬁrst analyzed for single nucleotide polymorphisms (SNPs) between
two mouse subspecies: Mus musculus domesticus (strains C57BL/6 and
129X1/Sv, abbreviated D) and Mus musculus castaneus (strain Cast/EI,
abbreviated C). Sequencing the nine regions of theMeg3DMR identiﬁed
SNPs that alter a restriction enzyme recognition site in regions 3 and 9,
allowing allele-speciﬁc analysis at these two regions.When the region 3
PCR product is digested with the restriction enzymeMboI, D DNA is cut
into two fragments, whereas C DNA is not cut. When the region 9 PCR
product is digested with the restriction enzyme HinfI, D DNA is cut
into two fragments of 258 and 41 base pairs, and C DNA is cut into
three fragments of 192, 67, and 41 base pairs. Only the 258 and 192
base pair fragments are shown for region 9 (Fig. 1C).
ForMeg3 DMR methylation analysis, 129X1/Sv (D)×Cast/Ei (C) F1
ES cell DNA and C57BL/6 (D)×B6.CAST-D12Mit30-D12Mit263 (Cg12)
F1 e12.5 embryo DNA was used. Cg12 mice are a congenic strain car-
rying a C-derived Dlk1–Meg3 interval on a D background [16]. After
digestion with the methylation sensitive enzyme HpaII, DNA was
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1), and the resulting products were digested with the appropriate re-
striction enzyme. The percent of maternal allele in the digested sam-
ple was calculated to determine allele-speciﬁcity. DNA methylation
was considered allele-speciﬁc if the sample contained more than
80% of one parental allele. The data showed that in ES cells, the
Meg3 DMR is biallelically methylated at region 3, but is methylated
only on the paternal allele at region 9. This variable DNA methylation
may reﬂect an intermediate state as imprinting is in the process of
being established. As expected, methylation is paternal-speciﬁc at
both regions 3 and 9 in e12.5 embryos (Fig. 1C).
To determine the imprinting status of Meg3 in D×C ES cells,
expression analysis of Meg3 was carried out as described [6], using
cDNA from D×C ES cells. Parental D and C cDNAs, as well as those
from D×C and C×D e12.5 embryo, were used as controls. PCR ampliﬁ-
cation withMeg3-speciﬁc primers was followed by digestion with SfcI,
which cuts only the D allele. Meg3 was found to be expressed from
both parental alleles in ES cells, but was fully imprinted in e12.5 embry-
os, with expression only from the maternal allele (Fig. 1D).
2.2. Histone modiﬁcations at the Meg3 DMR in ES cells
Acetylation of histones is commonly associated with transcriptional
activity; acetylation of histone H3 (H3ac), histone H4 (H4ac), and his-
toneH4 lysine 91 (H4K91ac) all promote the transcription of associated
genes [17]. Phosphorylation of histone H3 serine 10 (H3S10phos),
mono-, di-, and tri-methylation of histone H3 lysine 4 (H3K4me,
H3K4me2, H3K4me3), and mono-methylation of lysine 79 of histone
H3 (H3K79me) have also been associated with transcriptional activa-
tion [17]. Many different histone modiﬁcations have been identiﬁed at
various imprinted loci, often applied in an allele-speciﬁc manner that
correlates with imprinted expression. In mouse embryonic ﬁbroblast
cells (MEFs), H3ac, H4ac, and H3K4me3 have been detected at the ma-
ternal DMR of the active H19 allele, the promoter of the active paternal
Snrpn allele, and the maternal allele of the IG-DMR [18]. H3K4me3 was
present at the maternal allele of the IG-DMR in ES cells [19]. H3K79me
and H4K91ac have been observed at DMR1, DMR2, and the promoter of
the active paternal Igf2 allele in MEFs [17].
Histone methylation may also be linked to transcriptional repres-
sion. For example, di- and tri-methylation of histone H3 lysine 9
(H3K9me2, H3K9me3), tri-methylation of histone H3 lysine 27
(H3K27me3), tri-methylation of histone H4 lysine 20 (H4K20me3),
and tri-methylation of histone H3 lysine 79 (H3K79me3) are associated
with silent chromatin [17]. In MEFs, ES cells, and the murine brain,
H3K9me3 has been detected at the inactive maternal promoter of
Snrpn [18,20]. This inactive Snrpn allele also carries H3K27me3 in ES
cells, and H4K20me3 in the mouse brain [18,20]. In ES cells, H3K9me2
and H3K27me3 were present at the promoter of the inactive paternal
Kcnq1 allele [21]. In MEFs, H3K9me3 was found at the paternal allele
of the IG-DMR, andH3K79me3 has been detected at the imprinting con-
trol region and promoter of the inactive H19 allele [17,18].
To determine the pattern of histone modiﬁcations at theMeg3 DMR
of the early mouse embryo, ChIP was conducted using D×C ES cells. As
ES cells are derived from the inner cell mass of the e3.5 mouse blasto-
cyst, they approximate the early mouse embryo. Following immuno-
precipitation with an antibody of interest, the immunoprecipitated
DNA was ampliﬁed using primers corresponding to each region of the
Meg3 DMR (Supplementary Table 1). The percent precipitation of a
given histone modiﬁcation was determined by dividing the signal of a
particular modiﬁcation by the input signal and subtracting the normal-
ized IgG signal. In many ChIP analyses, the convention has been to re-
port modiﬁcations as simply present or absent. To introduce greater
quantitative rigor to the data, and therefore make determinations
about imprinting status, we established cutoffs for reporting a modiﬁca-
tion as positive. These cutoffs were determined by the signal-to-noise
observed in our rawdata, and the ability to conﬁdently call amodiﬁcationas present above background. For this study, a histone modiﬁcation was
considered to be present at the Meg3 DMR if it had a calculated percent
precipitation of 5% or greater.
The activating histone modiﬁcations H3ac, H4ac, H3K4me,
H3K4me2, H3K4me3, H3S10phos, H3K79me and H4K91ac, and the
repressive modiﬁcations H3K9me3, H3K27me3, H4K20me3 and
H3K79me3, were present at all regions of the Meg3 DMR tested. Per-
cent precipitations across the DMR ranged from 10% to 365%. While
many biological and technical variables contribute to percent precip-
itation, this range suggests there may be differences in abundance of
the various modiﬁcations (Fig. 2, Supplementary Table 3). H3K9me2
was present across the entire Meg3 DMR except at region 7 where
the percent precipitation of this modiﬁcation was 4%, just below the
cutoff for a positive result (Fig. 2B, Supplementary Table 3).
2.3. Allele-speciﬁcity of histone modiﬁcations at the Meg3 DMR in ES cells
To determine the allele-speciﬁcity of histone modiﬁcations
detected in D×C ES cells, immunoprecipitated DNA was ampliﬁed
with region 3 and region 9 primers (the two regions with informative
SNPs), and the resulting PCR products were digested with MboI and
HinfI respectively, as described for the DNA methylation analysis.
The percent of maternal allele in the digested sample was calculated,
and modiﬁcations that exhibited parental bias of 80% or greater were
considered to be allele-speciﬁc. This analysis revealed that at regions
3 and 9 of the Meg3 DMR, all histone modiﬁcations were present in a
biallelic distribution in ES cells (Fig. 3, Supplementary Table 4). The
presence of both activating and repressing histone modiﬁcations at
the Meg3 DMR corresponds to the biallelic expression of Meg3 in ES
cells. Similarly to the variable DNA methylation across this region in
ES cells, histone modiﬁcations may also be in a state of ﬂux as the im-
printing process is ongoing.
2.4. Histone modiﬁcations at the Meg3 DMR in e12.5 embryos
ChIP was then used to analyze the Meg3 DMR of D×Cg12 e12.5
embryos for the histone modiﬁcations studied in ES cells. ChIP analy-
sis revealed that the activating modiﬁcations H3ac, H4ac, H3K4me2,
H3K4me3, and H3K79me were present across the Meg3 DMR (Figs.
4A and C, Supplementary Table 5), while H3K4me, H3S10phos, and
H4K91ac were absent, with none exceeding 4% precipitation (Fig. 4,
Supplementary Table 5). For each of the active modiﬁcations
detected, enrichment was highest at region 6, which overlies Meg3
exon 1 and the beginning of the ﬁrst intron (Figs. 1B and 4, Supple-
mentary Table 5).
The repressive histone modiﬁcations H3K9me2, H3K9me3,
H3K27me3, H4K20me3, and H3K79me3 were largely absent from
the Meg3 DMR, but a few were found at speciﬁc regions. H3K27me3
was present at region 6 of the Meg3 DMR at 7% precipitation, and
H3K79me3 was present at regions 6 and 7 at 10% precipitation
(Figs. 4B and C, Supplementary Table 5). H3K9me2, H3K9me3, and
H4K20me3 were not detected at any DMR region (Fig. 4B). In general,
histone modiﬁcations were found at a lower level at theMeg3 DMR of
e12.5 embryos than in ES cells (Figs. 2 and 4). The absence of most of
the repressive histone modiﬁcations tested at theMeg3 DMR of e12.5
embryos, where imprinting is fully established, suggests that they are
not required for the maintenance of imprinted expression of Meg3 at
this stage.
2.5. Allele-speciﬁcity of histone modiﬁcations at the Meg3 DMR in e12.5
embryos
Histone modiﬁcations present at the Meg3 DMR of D×Cg12 e12.5
embryos were analyzed for allele-speciﬁc localization as described for
ES cells. This analysis revealed that H3Ac, H4Ac, H3K4me2, and
H3K4me3 localized to the maternal allele at regions 3 and 9 of the
Fig. 2. Analysis of histone modiﬁcations at Meg3 DMR regions R1 through R9 in ES cells. ChIP analysis of (A) H3ac, H4ac, H3K4me, H3K4me2, H3K4me3, (B) H3K9me2, H3K9me3,
H3K27me3, H4K20me3, H3S10phos, (C) H3K79me, H3K79me3, and H4K91ac. Left panels display a representative ChIP assay for each modiﬁcation at each region of the DMR. Right
panels depict the average percent precipitation for each modiﬁcation at each region of the DMR. Average percent precipitation was calculated from at least two independent ChIP
experiments. Error bars represent standard error of the mean (SEM).
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precipitated DNA was 82% or higher for each of these modiﬁcations
(Figs. 5A and B, Supplementary Table 6). The presence of the maternal
allele-speciﬁc activating modiﬁcations H3Ac, H4Ac, H3K4me2, and
H3K4me3 suggests that these histone modiﬁcations may play a
role in the maternal expression of Meg3. H3K79me was biallelically
distributed at these regions, with 70% maternal allele in immuno-
precipitated samples (Figs. 5A and B, Supplementary Table 6).
H3K4me, H3K9me2, H3K9me3, H3K27me3, H4K20me3, H3S10phos,
H3K79me3, and H4K91ac were not subjected to allele-speciﬁc analy-
sis as these modiﬁcations are not present at regions 3 and 9 which
carry informative SNPs (Fig. 4).2.6. Trans-acting DNA binding proteins at the Meg3 DMR of e12.5 embryos
and ES cells
In addition to histone modiﬁcations, trans-acting DNA binding pro-
teins play a role in the regulation of imprinted genes. Methyl-CpG bind-
ing proteins (MBPs), including methyl-CpG binding protein 2 (MECP2)
and the methyl-CpG binding domain proteins 1–4 (MBD1, 2, 3, and 4),
are capable of binding DNA at methylated CpG dinucleotides through a
methyl-binding domain [22,23].MBPs have the ability to recruit histone
deacetylase complexes (HDACs) resulting in transcriptional repression
[24–27]. MECP2 has been detected at the maternal allele of the pater-
nally expressedU2af-rs1(Zrsr1) gene and at theMeg3DMR in the brains
Fig. 3. Allele-speciﬁc analysis of histone modiﬁcations atMeg3 DMR regions R3 and R9 in ES cells. (A) The region 3 product was cut withMboI and the region 9 product was cut with
HinfI to distinguish the maternal and paternal alleles of the DMR. Paternal and maternal bands are indicated by “P” and “M” respectively. The uncut PCR product is represented by
“−”, while “+” denotes the PCR product cut with the appropriate restriction enzyme. Average percent of maternal and paternal allele (%M and %P, respectively) of each histone
modiﬁcation present at region 3 (B) and region 9 (C) was calculated using data collected from at least two independent ChIP experiments. Error bars represent SEM.
188 E.N. McMurray, J.V. Schmidt / Genomics 100 (2012) 184–194of 8 week old mice. In these experiments, MECP2 localized approxi-
mately 700 base pairs downstream of the Meg3 DMR region tested
by Carr et al. [15,28,29]. MBD1 and MBD3 localized to the maternal
U2af-rs1(Zrsr1) allele, and MBD3 bound the DMR of the imprinted
H19 gene and was required for maintenance of H19 imprinting in
mouse blastocysts [29,30].
We tested MECP2, MBD1, and MBD3 for localization to the Meg3
DMR of ES cells and e12.5 embryos using ChIP. For this study, proteins
with percent precipitations above 2% were considered to be present
at the Meg3 DMR. As with the histone modiﬁcation analysis, this cut-
off was determined by the signal-to-noise observed in our raw data,
and the ability to conﬁdently call a modiﬁcation as present above
background. ChIP analysis demonstrated that MECP2 was present at
DMR regions 1, 3, 4, 5, and 6 in ES cells, and at all regions in e12.5
embryos, identifying new sites of MECP2 binding in this region
(Fig. 6). MBD1 and MBD3 were not present at any region of the
Meg3 DMR in ES cells (Fig. 6A), while in e12.5 embryos MBD3 was
detected at region 8 and MBD1 was detected at region 3 (Fig. 6B). The
presence of one ormoreMBDproteins is not surprising, as this correlateswith the fullymethylated paternal DMR in e12.5 embryos. LikeMBPs, the
protein Kaiso(Zbtb33) also binds methylated DNA, but does so through
a zinc ﬁnger domain [31]. In addition to binding methylated CpGs,
Kaiso(Zbtb33) candirectly bindDNA, and a putative Kaiso(Zbtb33) bind-
ing site is located in region 6 of theMeg3DMR. Kaiso(Zbtb33) has not yet
been found at any imprinted domains, but we detected it binding to
Meg3 DMR region 4 in ES cells. Kaiso(Zbtb33) was not present at any
region of theMeg3 DMR in e12.5 embryos (Figs. 6A and B).
Polycomb group proteins are typically associated with transcrip-
tional repression and play a role in the maintenance of imprinting
and X-inactivation [21,32]. EED belongs to this protein family, and
mice lacking the Eed gene display biallelic expression of several
imprinted genes including Meg3 [33,34]. EED interacts with HDACs
and has been suggested to interact with DNA through YY1, a
multifunctional zinc ﬁnger protein that can act as either a transcrip-
tional activator or repressor [34–37]. Our previous studies showed
that YY1 does not recognize a putative YY1 binding site approximate-
ly 5 kb upstream of theMeg3 transcriptional initiation site [15]. In the
current study, EED and YY1 were tested for binding to theMeg3 DMR.
Fig. 4. Analysis of histone modiﬁcations at Meg3 DMR regions R1 through R9 in e12.5 embryos. ChIP analysis of (A) H3ac, H4ac, H3K4me, H3K4me2, H3K4me3, (B) H3K9me2,
H3K9me3, H3K27me3, H4K20me3, H3S10phos, (C) H3K79me, H3K79me3, and H4K91ac. Left panels show a representative ChIP assay for each modiﬁcation at each region of
the DMR. Right panels depict the average percent precipitation of each modiﬁcation at each region. Average percent precipitation was calculated from at least two independent
ChIP experiments. Error bars represent SEM.
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region 3 and another at region 8. The current analysis showed that
EED was not present at theMeg3 DMR in ES cells, while YY1 was pre-
sent at regions 3, 4, and 6 (Fig. 6A). In e12.5 embryos, EED was not
detected at any Meg3 DMR region, and YY1 was present at all nine
DMR regions (Fig. 6B).
The atypical histonemacroH2A1(H2afy) is incorporated into the silent
X chromosome in femalemammals, suggesting it plays a role in transcrip-
tional repression [38]. Recently, macroH2A1(H2afy)was found to localize
to the paternal allele of theMeg3 DMR in the brain and liver of neonatal
mice [28]. We show here that in both ES cells and e12.5 embryos,
macroH2A1(H2afy) is present at all nine regions of theMeg3DMR (Fig. 6).
The protein CTCF localizes to several imprinted domains [39–44]. At
the Igf2/H19 locus, CTCF binds the maternal imprinting control region,
silencing the Igf2 gene by preventing its interaction with downstream
enhancers [41]. CTCF plays a role in chromatin looping, generatingchromosomal domains permissive and restrictive for transcription
that are required for proper imprinted gene expression at H19 and
other loci [45,46]. Previous studies showed that CTCF does not bind to
a putative site in the ﬁrst intron of Meg3 in e12.5 embryos, but it has
been detected at the Meg3 DMR in MEFs and human ﬁbroblast cells
[15,47,48]. In the current study, CTCF was detected at DMR region 9 in
ES cells, but was not detected at any region in e12.5 embryos (Fig. 6).
All ChIP results from this work are summarized in Table 1.
3. Discussion
3.1. Expression and methylation analysis
Previous studies have demonstrated that the Meg3 DMR is re-
quired for proper imprinting of Dlk1 and Meg3, but the factors neces-
sary for this regulation remain elusive [5,13–15]. The goal of the
Fig. 5. Allele-speciﬁc analysis of histone modiﬁcations at Meg3 DMR regions R3 and R9
in e12.5 embryos. (A) The region 3 product was cut withMboI and the region 9 product
was cut with HinfI to distinguish the maternal and paternal alleles of the DMR. Paternal
and maternal bands are indicated by “P” and “M” respectively. The uncut PCR product
is represented by “−” , while “+” denotes the PCR product cut with the appropriate re-
striction enzyme. Average percent of maternal and paternal allele (%M and %P, respec-
tively) of each histone modiﬁcation present at region 3 (B) and region 9 (C) was
calculated using data collected from at least two independent ChIP experiments.
Error bars represent SEM.
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embryos for the presence of DNAmethylation, histonemodiﬁcations and
DNA binding proteins that may play a role in regulation of Dlk1–Meg3
imprinting.
Methylation sensitive PCR revealed that in ES cells, DNA methyla-
tion is biallelic at DMR region 3, but localized to the paternal allele at
region 9, the two regions that carry SNPs for allele-speciﬁc analysis
(Fig. 1C). These data suggest a pattern of partial methylation acrossthe paternal DMR in early mouse embryos. Despite the presence of
some paternal-speciﬁc methylation at the ES cell DMR, allele-
speciﬁc analysis showed that the Meg3 gene is biallelically expressed
in these cells (Fig. 1D). In e12.5 embryos, theMeg3 DMR has acquired
the appropriate paternal methylation at both regions 3 and 9
(Fig. 1C), suggesting fully established allele-speciﬁc methylation
across the paternal DMR. This pattern correlates with the paternal si-
lencing of theMeg3 gene in midgestation embryos (Fig. 1D). Our data
suggest that the epigenetic status of the Meg3 DMR in ES cells repre-
sents a window into the establishment phase of the Dlk1–Meg3 im-
print, with key paternal silencing marks still being applied, while
the epigenetic status of e12.5 embryos represents a fully mature im-
print. The region 9 paternal-speciﬁc methylation suggests that certain
CpG dinucleotides within the DMR are methylated earlier than others,
and may serve to nucleate methylation spreading across the DMR.
3.2. Chromatin regulatory factors in embryonic stem cells
In ES cells, both activating and repressive histonemodiﬁcations were
found at the Meg3 DMR, and allele-speciﬁc analysis revealed that all
modiﬁcations present were biallelically distributed at regions 3 and 9
(Figs. 2 and 3). These data mirror the biallelic expression of the Meg3
gene at this stage, and contrast with the ﬁnding of partial allele-speciﬁc
DNA methylation in ES cells. Several trans-acting DNA binding proteins
were also detected at the Meg3 DMR of ES cells; the histone variant
macroH2A1(H2afy) was present at all DMR regions, while the transcrip-
tion factors MECP2, YY1, Kaiso(Zbtb33), and CTCF were detected only at
speciﬁc regions (Fig. 6A). Putative YY1 binding sites are located in re-
gions 3 and 8, and YY1 was detected at regions 3, 4, and 6. A putative
Kaiso(Zbtb33) binding site is located in region 6, but Kaiso(Zbtb33)
was detected at region 4. No consensus CTCF binding sites are contained
within theMeg3 DMR, but CTCF was found to localize to region 9. These
data illustrate the difﬁculty in predicting transcription factor binding by
sequence analysis alone. Each of these proteins has a highly variable
consensus sequence, and as we demonstrate, is capable of binding re-
gions of DNA without a recognizable binding site. The presence of
MECP2, YY1, Kaiso(Zbtb33), and CTCF at speciﬁc regions of the Meg3
DMR suggests that they may play a yet unknown role in the establish-
ment ofMeg3 imprinted expression (Fig. 1D).
3.3. Chromatin regulatory factors in midgestation embryos
In midgestation mouse embryos, the activating modiﬁcations
H3ac, H4ac, H3K4me2, H3K4me3, and H3K79me, were detected at
all regions of the Meg3 DMR (Figs. 4A and C). With the exception of
H3K79me, all modiﬁcations were maternal-speciﬁc at DMR regions
3 and 9 (Fig. 5). These maternal-speciﬁc modiﬁcations likely act to
specify the transcriptionally active state of the maternal Meg3 allele.
Repressive histone modiﬁcations were largely absent from the Meg3
DMR in e12.5 embryos, with H3K27me3 and H3K79me3 showing
slight enrichment at speciﬁc DMR regions. Therefore, it is unlikely
that repressive histone modiﬁcations play a role in the maintenance
ofMeg3 imprinting in midgestation mouse embryos, perhaps because
continued silencing of the paternal allele can be achieved through
DNA methylation alone.
A number of trans-acting DNA binding proteins were also detected at
the Meg3 DMR of e12.5 embryos, and differences between ES cells and
midgestation embryos suggest a dynamic pattern of trans-acting protein
activity. Kaiso(Zbtb33) and CTCF, proteins that are found at the Meg3
DMR of ES cells, are no longer present in e12.5 embryos, suggesting
theymay be involved in establishment of imprinting but are unnecessary
beyond this stage. On the other hand,MECP2 and YY1,which are found at
some DMR regions in ES cells, are found across all regions of the DMR in
midgestation embryos. The proteins MBD3 and MBD1 which are not
present at the Meg3 DMR of ES cells, localize to speciﬁc regions of the
e12.5Meg3DMR. The proteinmacroH2A1(H2afy) is present at all regions
Fig. 6. Analysis of transcription factors at Meg3 DMR regions R1 through R9 in ES cells and e12.5 embryos. ChIP analysis of macroH2A1, MeCp2, EED, YY1, MBD3, Kaiso, MBD1, and
CTCF in (A) D×C ES cells and (B) D×Cg e12.5 embryos. Each panel depicts the average percent precipitation of a given protein at each region of the Meg3 DMR. Average percent
precipitation was calculated from at least two independent ChIP experiments. Error bars represent SEM.
Table 1
Summary of ES cell and e12.5 embryo ChIP results at regions 1–9 of the Meg3 DMR.
ES cells e12.5 embryos
R1 R2 R3 R4 R5 R6 R7 R8 R9 R1 R2 R3 R4 R5 R6 R7 R8 R9
H3ac + + + + + + + + + + + + + + + + + +
H4ac + + + + + + + + + + + + + + + + + +
H3K4me + + + + + + + + + − − − − − − − − −
H3K4me2 + + + + + + + + + + + + + + + + + +
H3K4me3 + + + + + + + + + + + + + + + + + +
H3K9me2 + + + + + + − + + − − − − − − − − −
H3K9me3 + + + + + + + + + − − − − − − − − −
H3K27me3 + + + + + + + + + − − − − − + − − −
H4K20me3 + + + + + + + + + − − − − − − − − −
H3S10phos + + + + + + + + + − − − − − − − − −
H3K79me + + + + + + + + + + + + + + + + + +
H3K79me3 + + + + + + + + + − − − − − + + − −
H4K91ac + + + + + + + + + − − − − − − − − −
macroH2A1 + + + + + + + + + + + + + + + + + +
MeCp2 + − + + + + − − − + + + + + + + + +
EED − − − − − − − − − − − − − − − − − −
YY1 − − + + − + − − − + + + + + + + + +
MBD3 − − − − − − − − − − − − − − − − + −
Kaiso − − − + − − − − − − − − − − − − − −
MBD1 − − − − − − − − − − − + − − − − − −
CTCF − − − − − − − − + − − − − − − − − −
Shown is the presence or absence of a histone modiﬁcation or DNA binding protein at a particular Meg3 DMR region in ES cells and e12.5 embryos. "+" denotes the presence and
"−" denotes the absence of a given histone modiﬁcation or protein.
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role for the factors MECP2, YY1, MBD3, and/or MBD1 may be the
removal of the activating H3ac and H4ac modiﬁcations from the
paternal Meg3 DMR, as all of these proteins are capable of recruiting
HDACs. Since HDACs interact with DNA methyltransferases (DNMTs),
removal of the activating modiﬁcations may reinforce the methylation
of the paternal Meg3 DMR and therefore also reinforce the silencing of
the paternal Meg3 gene [49,50]. The interaction between DNA binding
proteins, HDACs, and DNMTs would result in the stable silencing of
the paternalMeg3 allele, while leaving the maternalMeg3 allele active.
3.4. Conclusion
This study provides a window into the temporal progression of the
epigenetic modiﬁcations and DNA binding proteins associated with
imprinting establishment at the Dlk1–Meg3 DMR. These data suggest
that multiple chromatin regulatory pathways must interact to confer
proper imprinting at this locus, and that those regulators responsible
for imprinting establishment are likely distinct from the regulators
necessary for imprinting maintenance. These data also suggest that
epigenetic modiﬁcations may work in concert with DNA binding pro-
teins to ensure stable silencing of the paternal Meg3 allele indepen-
dently of the maternal allele. Future work will determine the role
each histone modiﬁcation and/or DNA binding protein plays in the es-
tablishment and maintenance of Dlk1–Meg3 imprinting.
4. Materials and methods
4.1. Propagation of ES cells
129X1/Sv×Cast/Ei (D×C) ES cellswere obtained fromStemgent Inc.
and were maintained in Dulbecco's Modiﬁed Eagle Medium (DMEM)
containing high glucose (4.5 g/l) with 15% ES cell qualiﬁed fetal bovine
serum, 2 mM L-glutamine, 100 μg/ml penicillin/streptomycin, 1 μl/
100 ml β-mercaptoethanol, and 10 μl/100 ml LIF. Cells were grown on
mouse embryonic ﬁbroblast feeder cells and were maintained in a hu-
midiﬁed incubator at 37 °C with 5% CO2. The cells were frozen or split
1:5 when they reached 80% conﬂuence. For ChIP, cells were grown to
80% conﬂuency on 10 cm plates, trypsinized, resuspended, and plated
for 1 h to remove feeder cells. The ES-enriched supernatant was re-
moved from the plate and used for ChIP analysis.
4.2. Mouse maintenance and breeding
Embryos were analyzed at midgestation (e12.5) and were the off-
spring from a cross between the M. m. domesticus strain C57BL/6 and
the congenic mouse strain B6.CAST-D12Mit30-D12Mit263 (Cg12)
[16]. Animals were maintained in microisolator cages, on a standard
diet, with a 14:10 light:dark cycle. All animals used in these experi-
ments were maintained in compliance with the National Institutes
of Health's Guide for the Care and Use of Laboratory Animals and The
University of Illinois at Chicago Animal Care Committee guidelines.
4.3. Identiﬁcation of SNPs
Regions 1–9 were PCR ampliﬁed from C57BL/6, 129X1/Sv and
Cg12 genomic DNA and sequenced to identify SNPs. The strains
C57BL/6, 129X1/Sv belong to the D subspecies, and Cg12 is a congenic
line carrying a C-derived distal chromosome 12 on a D background
[16]. A SNP in region 3 was identiﬁed that abolishes an MboI restric-
tion site in Cg12 DNA, and a SNP in region 9 alters a HinfI site. MboI
digestion of region 3 gives 190 and 90 base pair fragments from D
DNA, while C or Cg12 DNA is not cut. HinfI digestion of region 9
DNA gives 258 and 41 base pair fragments from D DNA, and 192,
67, and 41 base pair fragments from C or Cg12 DNA. Only the 258and 192 base pair fragments are shown in the ﬁgures for region 9
analysis.
4.4. Determination of Meg3 DMR methylation status in ES cells and e12.5
embryos
Two hundred nanograms of genomic DNA from D×Cg12 e12.5
embryos and D×C ES cells was digested with 20 U of HpaII overnight.
Digested DNA was ampliﬁed with region 3 and region 9 primers, with
conditions 95 °C for 30 s, 60 °C for 30 s, and 70 °C for 30 s. After
25 cycles, 0.3 μCi [α-32P]dCTP (PerkinElmer) was added, and ampliﬁ-
cation resumed. Region 3 reactions were carried out for a total of
32 cycles, while region 9 reactions were carried out for 34 cycles.
PCR products were puriﬁed using the QIAquick PCR Puriﬁcation Kit
(Qiagen). The region 3 product was cut overnight at 37 °C with
MboI and region 9 was cut for 1 h at 37 °C with HinfI. Digested PCR
products were separated on a 7.5% acrylamide gel, and the gel was
dried and exposed to ﬁlm, and then to a phosphorimaging screen.
Phosphorimaging screens were scanned using a Molecular Dynamics
Storm 860 Phosphorimager, and the maternal and paternal alleles
were quantiﬁed using ImageQuant Software.
4.5. Determination of Meg3 imprinting status in ES cells and e12.5
embryos
Total RNA was extracted from D, C, D×C, and C×D e12.5 embryos
and from approximately 3×106 D×C ES cells with Trizol (Invitrogen)
according to manufacturer's instructions. RNA was treated with
TURBO DNA-free DNAse (Ambion). Oligo-dT-primed reverse tran-
scription reactions were carried out using 2 μg total RNA and Super-
script III (Invitrogen). Imprinting analysis of the Meg3 gene was
performed as described using 2 μl of a 1:10 dilution of the RT reac-
tions [6]. After 25 cycles, 0.3 μCi [α-32P]dCTP (PerkinElmer) was
added to each reaction. PCR products were run on a 7.5% acrylamide
gel, dried, and exposed to ﬁlm. Control reactions carried out in the ab-
sence of reverse transcriptase were negative.
4.6. Preparation of nuclei for chromatin immunoprecipitation
Nuclei were prepared using the Millipore ChIP Assay Kit according
to the manufacturer's instructions with the following modiﬁcations.
Midgestation embryos were minced with a razor blade and
crosslinked with 1% formaldehyde in DMEM. When testing for the
presence of histone modiﬁcations, cells were crosslinked for 10 min.
When testing for the presence of a DNA binding protein, cells were
crosslinked for 20 min. The crosslinking reaction was stopped by the
addition of glycine to a concentration of 0.125 M for 5 min. The cells
were spun at 2000 rpm for 5 min, washed 2 times with wash buffer
(1× PBS containing 1 mM PMSF, 1 μg/ml aprotinin, and 1 μg/ml
pepstatin A) and homogenized in a dounce homogenizer with a
tight pestle for 3 cycles of 10 strokes with a 2 minute rest between cy-
cles. The nuclei were washed twice with wash buffer, split into two
equal fractions, pelleted, and the pellets were snap frozen.
To prepare ES cell nuclei, 1×106 ES cells were crosslinked and
treated as described above with the following changes. ES cells
were homogenized in a dounce homogenizer with a tight pestle for
2 cycles of 10 strokes with a 2 minute rest between cycles. ES cell nu-
clei were not split into two fractions before snap freezing.
4.7. Chromatin immunoprecipitation
ChIP was carried out on nuclei from e12.5 embryos and ES cells
using the Millipore ChIP Assay Kit according to the manufacturer's in-
structions with the following modiﬁcations. One tube of previously
prepared nuclei was thawed on ice, the pellet was resuspended in
200 μl of SDS lysis buffer, and was incubated on ice for 10 min. The
193E.N. McMurray, J.V. Schmidt / Genomics 100 (2012) 184–194nuclei were sonicated using a Branson Model 450 sonicator with a
double-step tip for 150 s (10 cycles of 15 s with a 2 minute rest be-
tween cycles) at 30% power. Chromatin was diluted in ChIP dilution
buffer and divided into two fractions. One fraction was treated with
the antibody against the histone modiﬁcation or protein of interest,
and the other was treated with a preimmune antibody to serve as a
negative control. Chromatin was pre-cleared with 75 μl Protein A/G
PLUS-Agarose (Santa Cruz Biotechnology) for 1 h at 4 °C. For immu-
noprecipitation, 10 μg of antibody against a histone modiﬁcation or
20 μg of antibody against a protein was added to the chromatin and
was incubated overnight at 4 °C.4.8. Collection of immune complexes and DNA puriﬁcation
Antibody/protein/DNA complexes were collected by the addition
of 60 μl Protein A/G PLUS-Agarose that had been blocked overnight
at 4 °C in 5% BSA in ChIP Dilution Buffer. The immune complex was
washed, the DNA/protein complex was eluted from the beads, DNA/
protein crosslinks were reversed, and the protein was digested as de-
scribed in the Millipore ChIP Assay Kit instructions. DNA was puriﬁed
using the MinElute PCR Puriﬁcation Kit (Qiagen) according to the
manufacturer's instructions and was resuspended in 20 μl dH2O.4.9. PCR ampliﬁcation
PCR was conducted using region 1–9 primers (Supplementary
Table 1) and 1 μl of DNA from DNA binding protein immunoprecipita-
tions or 1 μl of a 1:2 dilution of DNA from histone modiﬁcation immu-
noprecipitations. The conditions for all PCR reactions were 95 °C for
30 s, 60 °C for 30 s, and 72 °C for 30 s. After 25 cycles, 0.3 μCi [α-32P]
dCTP (PerkinElmer) was added, and the PCR was resumed for the
necessary number of cycles. For regions 1–5 and 7–10, DNA from ES
cell histone modiﬁcation immunoprecipitations, e12.5 histone modi-
ﬁcation immunoprecipitations, ES cell protein immunoprecipitations,
and e12.5 protein immunoprecipitations was ampliﬁed for 33, 31, 30,
and 28 total cycles respectively. Regions 6 and 11 were ampliﬁed for
35, 33, 32, and 30 total cycles respectively. All PCR reactions carried
out without template DNA were negative. Ten microliters of the PCR
reaction was separated on a 7.5% acrylamide gel. The gel was dried
and exposed to ﬁlm and to a phosphorimaging screen. Phospho-
rimaging screens were scanned using a Molecular Dynamics Storm
860 Phosphorimager, and the intensity of each band was quantiﬁed
using ImageQuant Software. The IP signal was ﬁrst normalized by di-
viding the intensity of the signal by the intensity of the corresponding
input signal. Percent precipitation was then determined by multiplying
the normalized IP signal by 100. To determine the allele-speciﬁcity of a
histonemodiﬁcation, regions 3 and 9 were cut with the appropriate re-
striction enzymeas described above and separated on a 7.5% acrylamide
gel that was subsequently dried and exposed to a phosphoimaging
screen. Phosphorimaging screens were scanned using a Molecular
Dynamics Storm 860 Phosphorimager, and the bands were quantiﬁed
using ImageQuant Software. The signal fromeach allelewas normalized
to the input DNA as described, and the percentage of maternal allele
present in the sample was calculated.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ygeno.2012.06.001.Acknowledgments
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